Thus, the results demonstrated an intense AQP5 labeling in the invasive cancer cells combined with the gradual decrease of AQP5 labeling in the ductal cells, along with the loss of AQP5 polarity in the apical plasma membrane domain during the progression of breast carcinoma. The gene discussed is AQP5; the disease is breast carcinoma.